Last reviewed · How we verify

Entonox

University of Oxford · FDA-approved active Small molecule ✓ Verified May 2026

Entonox is a Small molecule drug developed by University of Oxford. It is currently FDA-approved. Also known as: Oxygen 50.0% +/- 2.0%, Nitrous oxide 50.0% +/- 2.0%, Entonox gas, Laughing gas.

Entonox is a small molecule used as a pain medication, typically administered as a 50% nitrous oxide and 50% oxygen mix. It is often used during childbirth, and its effects are usually noticeable within half a minute, lasting for about a minute.

At a glance

Generic nameEntonox
Also known asOxygen 50.0% +/- 2.0%, Nitrous oxide 50.0% +/- 2.0%, Entonox gas, Laughing gas
SponsorUniversity of Oxford
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Entonox

What is Entonox?

Entonox is a Small molecule drug developed by University of Oxford.

Who makes Entonox?

Entonox is developed and marketed by University of Oxford (see full University of Oxford pipeline at /company/university-of-oxford).

Is Entonox also known as anything else?

Entonox is also known as Oxygen 50.0% +/- 2.0%, Nitrous oxide 50.0% +/- 2.0%, Entonox gas, Laughing gas.

What development phase is Entonox in?

Entonox is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing